DE3782939T2 - Kristalline cephalosporinderivate. - Google Patents

Kristalline cephalosporinderivate.

Info

Publication number
DE3782939T2
DE3782939T2 DE8787810505T DE3782939T DE3782939T2 DE 3782939 T2 DE3782939 T2 DE 3782939T2 DE 8787810505 T DE8787810505 T DE 8787810505T DE 3782939 T DE3782939 T DE 3782939T DE 3782939 T2 DE3782939 T2 DE 3782939T2
Authority
DE
Germany
Prior art keywords
crystalline
cephalosporine derivatives
cephalosporine
derivatives
hylethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787810505T
Other languages
English (en)
Other versions
DE3782939D1 (de
Inventor
Bernhard Christian Prager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz GmbH
Original Assignee
Biochemie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie GmbH filed Critical Biochemie GmbH
Publication of DE3782939D1 publication Critical patent/DE3782939D1/de
Application granted granted Critical
Publication of DE3782939T2 publication Critical patent/DE3782939T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
DE8787810505T 1986-06-04 1987-09-02 Kristalline cephalosporinderivate. Expired - Fee Related DE3782939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0151186A AT387022B (de) 1986-06-04 1986-06-04 Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats
EP87810505A EP0305625B1 (de) 1986-06-04 1987-09-02 Kristalline Cephalosporinderivate

Publications (2)

Publication Number Publication Date
DE3782939D1 DE3782939D1 (de) 1993-01-14
DE3782939T2 true DE3782939T2 (de) 1993-05-27

Family

ID=39672041

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787810505T Expired - Fee Related DE3782939T2 (de) 1986-06-04 1987-09-02 Kristalline cephalosporinderivate.

Country Status (8)

Country Link
US (2) US4826972A (de)
EP (1) EP0305625B1 (de)
JP (1) JP2525013B2 (de)
AT (2) AT387022B (de)
DE (1) DE3782939T2 (de)
ES (1) ES2043687T3 (de)
GR (1) GR3006853T3 (de)
HK (1) HK43196A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
BE885488A (fr) * 1979-10-02 1981-04-01 Glaxo Group Ltd Bischlorhydrate de cephalosporine et sa preparation
DE3381408D1 (de) * 1982-12-27 1990-05-10 Lilly Co Eli Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
IT8448798A0 (it) * 1983-09-12 1984-09-05 Biochemie Gmbh Procedimento per la preparazione di antibiotici del tipo cefalosporina
DE3587866D1 (de) * 1984-04-10 1994-07-28 Biochemie Gmbh Cephalosporinzwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung.
CA1236089A (en) * 1984-06-25 1988-05-03 Perry C. Heath Ceftazidime

Also Published As

Publication number Publication date
JP2525013B2 (ja) 1996-08-14
ES2043687T3 (es) 1994-01-01
GR3006853T3 (de) 1993-06-30
EP0305625A1 (de) 1989-03-08
EP0305625B1 (de) 1992-12-02
US4826972A (en) 1989-05-02
AT387022B (de) 1988-11-25
DE3782939D1 (de) 1993-01-14
ATA151186A (de) 1988-04-15
JPS6471884A (en) 1989-03-16
HK43196A (en) 1996-03-22
US5066798A (en) 1991-11-19
ATE82977T1 (de) 1992-12-15

Similar Documents

Publication Publication Date Title
ECSP941099A (es) Mejoras relativas a un antibiotico de cefalosporina
MY101117A (en) Cephalosporin derivatives
IL77676A (en) 7-(2-(2-amino-1,3-thiazol-4-yl)-2-carbazoyl-acetamino)-3-cephem-4-carboxylic acid derivatives
PH23284A (en) 7-/2-(2-aminothiazol-4-yl)-2-(syn)-methoxyimino acetamido/ cephalosporin derivative
RO89362A (ro) Procedeu pentru prepararea unor derivati de cefalosporina
SE8003429L (sv) Heterocyklylderivat av oxi-imino-substituerade cefalosporiner samt forfarande for framstellning derav
AU571506B2 (en) Cristalline ceftazidime
DE3782939T2 (de) Kristalline cephalosporinderivate.
SE8104771L (sv) Cefalosporinderivat
DE68922629D1 (de) Ceftazidim-Dihydrochlorid-Ameisensäuresolvate.
EP0238061A3 (en) Cephalosporin derivatives, processes for their preparation and antibacterial agents
ATA387779A (de) Werkstoff zur pulvermetallurgischen herstellung von gegenstaenden mit hoher verschleissfestigkeit, sowie gegenstand daraus
EP0166580A3 (de) Herstellung von Ceftazidine
DE3375013D1 (en) Thiazole derivative, process for its preparation and use in the preparation of beta-lactam antibiotics
ES8507522A1 (es) Un procedimiento para la produccion de un derivado de 2-amino-tiazol.
AU569001B1 (en) 7-(2-(2-aminothiazol-4-yl)-2(substituted hydoxyimino)acetamido)-3-cephem derivatives
IL59269A (en) Process for preparing penicillin,cephalosporin,or 1-oxa-dethia cephalosporin imino halides
ES2173857T3 (es) Derivados de cefalosporina antibacterianos.
NO884486L (no) Fremgangsmaate for fremstilling av cefalosporinderivater med forbedrede farmakokinetika.
NO901418D0 (no) Cefalosporinderivater og deres fremstilling.
IT8119671A0 (it) 7-[(2-ammino-4-tiazolil) [ammino sostituite)alcossiimmino] acetammido]cefalosporine
ATA242786A (de) Verfahren zur herstellung einer neuen kristallinen, stabilen form des syn-isomeren des (6r,7r)-7-((2-(2-amino-4-thiazolyl)-(z)-2-(1-te t.butoxycarbonyl-1-methylethoxy)imino)acetamido -3- (1-pyridiniummethyl)-3-cephem-4-carboxylats
RO92344A (ro) Procedeu pentru prepararea unor derivati de cefalosporina
RO89786A (ro) Procedeu pentru prepararea unor derivati de cefalosporina
ES2063129T3 (es) Intermedio de la 1-carba(detia)cefalosporina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee